Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide/formoterol vs budesonide in inadequately controlled asthma
NCT05755906Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of formoterol in asthma, sponsored by AstraZeneca. Started Feb 2023; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05755906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05755906.